Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity
Clinical trial NCT01265849 · COMPLETED
Trial details
- NCT number
- NCT01265849
- Sponsor
- CEL-SCI Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2020-05-15
- Enrollment
- 928
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.